Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells.
about
Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis.Expansion of melanoma-specific lymphocytes in alternate gamma chain cytokines: gene expression variances between T cells and T-cell subsets exposed to IL-2 versus IL-7/15Natural killer T cell activation overcomes immunosuppression to enhance clearance of postsurgical breast cancer metastasis in mice.Addition of interleukin-21 for expansion of T-cells for adoptive immunotherapy of murine melanomaInfluence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp 70 Derived 14-Mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors on Peripheral Blood T Cells, B Cells and NKT CellsEpigenetic suppression of the antitumor cytotoxicity of NK cells by histone deacetylase inhibitor valproic acid.Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells.Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies.Expansion of T Cells with Interleukin-21 for Adoptive Immunotherapy of Murine Mammary CarcinomaImmune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment.Adoptive cellular therapy of cancer: exploring innate and adaptive cellular crosstalk to improve anti-tumor efficacy.Immunotherapeutic strategies targeting natural killer T cell responses in cancer.DNA methyltransferase inhibition increases efficacy of adoptive cellular immunotherapy of murine breast cancer.Perspectives on Systems Modeling of Human Peripheral Blood Mononuclear Cells.Immune Regulatory Function of Tregs.Tumor-induced CD14+HLA-DR (-/low) myeloid-derived suppressor cells correlate with tumor progression and outcome of therapy in multiple myeloma patients.
P2860
Q33641799-2455603C-52F5-4D15-ABA4-D7BA22A012D7Q34381488-72D0AD9C-3727-4569-AFBC-F1C39E074DD5Q35506478-2187E223-E706-4EC6-A51F-8DCB9C308B43Q35585735-27340C25-6C97-4558-B3F5-C1099A456AFCQ35959395-1AD4FBC3-042A-43BE-8BBE-20CA2CC7EB57Q36853857-E92B1592-74CD-4E9A-A6D2-5E34E1AACCFFQ37170767-2E6F734D-8167-4588-892A-BA05F0054C0BQ37665711-733C3E1B-A763-40B9-8A6F-D6D9F1CA50B8Q37690690-6B178B3C-37CE-4875-8CBD-B45C09DC29D2Q38221107-A29DB86C-B0CF-45BC-A266-8BE9A0AAC158Q38258842-397B9886-5FD5-4C79-8DFD-E8966C28ED9DQ38890717-1B71ABE5-FC04-4122-83CE-64763405E7BFQ41247038-C449C18E-CA39-4056-A4F9-C36B91855EF5Q49627122-4DD5CCFE-E6F1-4237-AA4F-D4BD5FBAEFA8Q51366875-B708560B-BC0A-49D7-B498-265678E84381Q53656759-8ED1EDC2-5C91-46C6-B7B6-EBABE4B6EDFD
P2860
Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Peripheral blood mononuclear c ...... loid-derived suppressor cells.
@en
type
label
Peripheral blood mononuclear c ...... loid-derived suppressor cells.
@en
prefLabel
Peripheral blood mononuclear c ...... loid-derived suppressor cells.
@en
P2093
P2860
P1476
Peripheral blood mononuclear c ...... eloid-derived suppressor cells
@en
P2093
A Latif Kazim
Christine K Zoon
Harry D Bear
Khin Marlar
Masoud H Manjili
Mehrab Nasiri Kenari
Rebecca C Keim
P2860
P2888
P356
10.1007/S10549-013-2733-5
P407
P50
P577
2013-10-25T00:00:00Z